San Diego, CA — 03/13/2018 — An investigation was announced for investors of Civitas Solutions Inc (NYSE:CIVI) shares over potential securities laws violations by Civitas Solutions Inc and certain of its directors and officers in connection with certain financial statements.
The investigation by a law firm focuses on whether a series of statements by Civitas Solutions Inc (NYSE:CIVI regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Boston, MA based Civitas Solutions, Inc. is a provider of home- and community-based health and human services to individuals with intellectual, developmental, physical or behavioral disabilities and other special needs. Civitas Solutions, Inc. markets its services nationally as The MENTOR Network, which is a national network of local health and human services providers in 36 states offering an array of quality, community-based services to adults and children with intellectual and developmental disabilities, brain and spinal cord injuries and other catastrophic injuries and illnesses.
On October 17, 2017, the United States Senate Committee on Finance issued a report detailing an investigation of foster care privatization. In this report, the Finance Committee used The MENTOR Network as a case study, determining that 'In MENTOR's case in particular, investigations into fatalities were never followed up after the fact; autopsy reports which were pending years ago were excluded from files; and the vast majority of children who died were not the subject of internal investigations, even when their deaths were unexpected. In addition, the Committee stated that The MENTOR Network has issued millions of dollars in settlements to families of 'victims of inadequate care
Those who purchased shares of Civitas Solutions Inc (NYSE:CIVI) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego
Latest posts by Sarah Thompson (see all)
- UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies - March 24, 2018
- Arena Pharmaceuticals to Present at the 17th Annual Needham Healthcare Conference on March 27 - March 24, 2018
- INGIC Gives a Facelift to Renault Iraq’s Website - March 24, 2018